Imaging Artifacts of Liquid Embolic Agents on Conventional CT in an Experimental in Vitro Model

References

1. 1.↵
   1. Friedlander RM

   . Clinical practice: arteriovenous malformations of the brain. N Engl J Med 2007;356:2704–12 doi:10.1056/NEJMcp067192 pmid:17596605

   CrossRefPubMedWeb of Science
2. 2.↵
   1. van Rooij WJ,
   2. Sluzewski M,
   3. Beute GN

   . Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007;28:172–77; discussion 178 pmid:17213451

   Abstract/FREE Full Text
3. 3.↵
   1. Weber W,
   2. Kis B,
   3. Siekmann R, et al

   . Endovascular treatment of intracranial arteriovenous malformations with Onyx: technical aspects. AJNR Am J Neuroradiol 2007;28:371–77 pmid:17297015

   Abstract/FREE Full Text
4. 4.↵
   1. Saatci I,
   2. Cekirge HS,
   3. Ciceri EF, et al

   . CT and MR imaging findings and their implications in the follow-up of patients with intracranial aneurysms treated with endosaccular occlusion with Onyx. AJNR Am J Neuroradiol 2003;24:567–78 pmid:12695183

   Abstract/FREE Full Text
5. 5.↵
   1. Mason JR,
   2. Dodge C,
   3. Benndorf G

   . Quantification of tantalum sedimentation rates in liquid embolic agents. Interv Neuroradiol 2018;24:574–79 doi:10.1177/1591019918773443 pmid:29781371

   CrossRefPubMed
6. 6.↵
   1. Varadharajan S,
   2. Ramalingaiah AH,
   3. Saini J, et al

   . Precipitating hydrophobic injectable liquid embolization of intracranial vascular shunts: initial experience and technical note. J Neurosurg 2018;129:1217–22 doi:10.3171/2017.6.JNS16447 pmid:29192863

   CrossRefPubMed
7. 7.↵
   1. Vollherbst DF,
   2. Otto R,
   3. Hantz M, et al

   . Investigation of a new version of the liquid embolic agent PHIL with extra-low-viscosity in an endovascular embolization model. AJNR Am J Neuroradiol 2018;39:1696–1702 doi:10.3174/ajnr.A5750 pmid:30093480

   Abstract/FREE Full Text
8. 8.↵
   1. Vollherbst DF,
   2. Sommer CM,
   3. Ulfert C, et al

   . Liquid embolic agents for endovascular embolization: evaluation of an established (Onyx) and a novel (PHIL) embolic agent in an in vitro AVM model. AJNR Am J Neuroradiol 2017;38:1377–82 doi:10.3174/ajnr.A5203 pmid:28522669

   Abstract/FREE Full Text
9. 9.↵
   1. Vollherbst DF,
   2. Otto R,
   3. von Deimling A, et al

   . Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model. J Neurointerv Surg 2018;10:268–74 doi:10.1136/neurintsurg-2017-013144 pmid:28689184

   Abstract/FREE Full Text
10. 10.↵
    1. Elsenousi A,
    2. Aletich VA,
    3. Alaraj A

    . Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerv Surg 2016;8:265–72 doi:10.1136/neurintsurg-2014-011427 pmid:25540177

    Abstract/FREE Full Text
11. 11.↵
    1. Gross BA,
    2. Albuquerque FC,
    3. Moon K, et al

    . Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas. J Neurosurg 2017;126:1884–93 doi:10.3171/2016.5.JNS16331 pmid:27588586

    CrossRefPubMed
12. 12.↵
    1. Chapot R,
    2. Stracke P,
    3. Velasco A, et al

    . The pressure cooker technique for the treatment of brain AVMs. J Neuroradiol 2014;41:87–91 doi:10.1016/j.neurad.2013.10.001 pmid:24405685

    CrossRefPubMed
13. 13.↵
    1. Vollherbst DF,
    2. Otto R,
    3. Do T, et al

    . Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model. Interv Neuroradiol 2018;24:693–701 doi:10.1177/1591019918782692 pmid:29973083

    CrossRefPubMed
14. 14.↵
    1. Pop R,
    2. Mertz L,
    3. Ilyes A, et al

    . Beam hardening artifacts of liquid embolic agents: comparison between Squid and Onyx. J Neurointerv Surg 2019;11:706–09 doi:10.1136/neurintsurg-2018-014542 pmid:30567844

    Abstract/FREE Full Text
15. 15.↵
    1. Lv X,
    2. Wu Z,
    3. Li Y, et al

    . Hemorrhage risk after partial endovascular n-BCA and Onyx embolization for brain arteriovenous malformation. Neurol Res 2012;34:552–56 doi:10.1179/1743132812Y.0000000044 pmid:22663933

    CrossRefPubMed
16. 16.↵
    1. Pereira GC,
    2. Traughber M,
    3. Muzic RF Jr..

    The role of imaging in radiation therapy planning: past, present, and future. Biomed Res Int 2014;2014:231090 doi:10.1155/2014/231090 pmid:24812609

    CrossRefPubMed
17. 17.↵
    1. Shtraus N,
    2. Schifter D,
    3. Corn BW, et al

    . Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted. J Neurooncol 2010;98:271–76 doi:10.1007/s11060-010-0177-x pmid:20383557

    CrossRefPubMed
18. 18.↵
    1. Roberts DA,
    2. Balter JM,
    3. Chaudhary N, et al

    . Dosimetric measurements of Onyx embolization material for stereotactic radiosurgery. Med Phys 2012;39:6672–81 doi:10.1118/1.4757918 pmid:23127061

    CrossRefPubMed
19. 19.↵
    1. Giantsoudi D,
    2. De Man B,
    3. Verburg J, et al

    . Metal artifacts in computed tomography for radiation therapy planning: dosimetric effects and impact of metal artifact reduction. Phys Med Biol 2017;62:R49–80 doi:10.1088/1361-6560/aa5293 pmid:28323641

    CrossRefPubMed
20. 20.↵
    1. Daubner D,
    2. Spieth S,
    3. Cerhova J, et al

    . Measuring ventricular width on cranial computed tomography: feasibility of dose reduction in a custom-made adult phantom. Rofo 2016;188:73–81 doi:10.1055/s-0041-106072 pmid:26566267

    CrossRefPubMed
21. 21.↵
    1. Nolden M,
    2. Zelzer S,
    3. Seitel A, et al

    . The Medical Imaging Interaction Toolkit: challenges and advances: 10 years of open-source development. Int J Comput Assist Radiology Surg 2013;8:607–20 doi:10.1007/s11548-013-0840-8 pmid:23588509

    CrossRefPubMed
22. 22.↵
    1. Weiß J,
    2. Schabel C,
    3. Bongers M, et al

    . Impact of iterative metal artifact reduction on diagnostic image quality in patients with dental hardware. Acta Radiol 2017;58:279–85 doi:10.1177/0284185116646144 pmid:27166346

    CrossRefPubMed
23. 23.↵
    1. Cohen J

    . A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46 doi:10.1177/001316446002000104

    CrossRefWeb of Science
24. 24.↵
    1. Altman DG

    . Practical Statistics for Medical Research. CRC Press; 1990
25. 25.↵
    1. Gross BA,
    2. Du R

    . Diagnosis and treatment of vascular malformations of the brain. Curr Treat Options Neurol 2014;16:279 doi:10.1007/s11940-013-0279-9 pmid:24318447

    CrossRefPubMed
26. 26.↵
    1. Rammos S,
    2. Bortolotti C,
    3. Lanzino G

    . Endovascular management of intracranial dural arteriovenous fistulae. Neurosurg Clin N Am 2014;25:539–49 doi:10.1016/j.nec.2014.04.010 pmid:24994089

    CrossRefPubMed
27. 27.↵
    1. Stoesslein F,
    2. Ditscherlein G,
    3. Romaniuk PA

    . Experimental studies on new liquid embolization mixtures (histoacryl-lipiodol, histoacryl-panthopaque). Cardiovasc Intervent Radiol 1982;5:264–67 doi:10.1007/BF02565409 pmid:6297733

    CrossRefPubMedWeb of Science